Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001662252-17-000191
Filing Date
2017-09-12
Accepted
2017-09-12 18:02:38
Documents
1
Period of Report
2017-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form3.html 3  
1 OWNERSHIP DOCUMENT form3.xml 3 4730
  Complete submission text file 0001662252-17-000191.txt   6264
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Genkin Dmitry (Reporting) CIK: 0001711592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37937 | Film No.: 171081898